Pancreatic Cancer Research

ResearcherUniversity of MiamiNo recent work listed

Kousik Kesh

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5009648827. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2018: 2 papers · 2019: 2 papers · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper

Papers 9

  1. Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC. Co-author DOI 10.1080/19490976.2022.2096328↗
  2. Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-2562↗
  3. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer. First author DOI 10.1093/carcin/bgz116↗
  4. Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. Co-author DOI 10.1172/jci127515↗
  5. Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12934-020-01330-3↗
  6. Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression,remodels extracellular matrix and sensitizes to anti-PD1 therapy Co-author DOI 10.1016/j.pan.2019.05.430↗
  7. O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability. Co-author DOI 10.7150/thno.32615↗
  8. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Co-author DOI 10.1016/j.canlet.2018.09.028↗
  9. Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression. Co-author DOI 10.1158/0008-5472.can-17-2320↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sulagna Banerjee · 9 shared papers, 2018–2022 · strength 0.95
  2. Vineet Kumar Gupta · 7 shared papers, 2018–2022 · strength 0.69
  3. Santanu Banerjee · 5 shared papers, 2018–2022 · strength 0.57
  4. Nikita Sharma · 6 shared papers, 2018–2021 · strength 0.54
  5. Ashok Kumar Saluja · 6 shared papers, 2018–2021 · strength 0.54
  6. Vikas Dudeja · 5 shared papers, 2018–2020 · strength 0.43
  7. Roberto Méndez · 3 shared papers, 2020–2022 · strength 0.41
  8. Bhuwan Giri · 4 shared papers, 2018–2020 · strength 0.35
  9. Nipun B. Merchant · 2 shared papers, 2020–2022 · strength 0.26
  10. Beatriz Mateo-Victoriano · 2 shared papers, 2021–2022 · strength 0.25
  11. Patricia Dauer · 3 shared papers, 2018–2019 · strength 0.24
  12. Anthony R. Ferrantella · 2 shared papers, 2019–2020 · strength 0.19
  13. Selwyn Maurice Vickers · 2 shared papers, 2018–2019 · strength 0.16
  14. Jashodeep Datta · 1 shared paper, 2022 · strength 0.15
  15. Florencia M. McAllister · 1 shared paper, 2020 · strength 0.12
  16. Sai Sundeep Kollala · 1 shared paper, 2021 · strength 0.11
  17. Pankaj Kumar Singh · 1 shared paper, 2021 · strength 0.11
  18. Xianda Zhao · 1 shared paper, 2018 · strength 0.08
  19. Alice Nomura · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.